Latest & greatest articles for measles

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on measles or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on measles and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for measles

41. Progress towards measles elimination in Nepal, 2007– 2014 = Progrès réalisés en vue d’éliminer la rougeole au Népal, 2007-2014

Progress towards measles elimination in Nepal, 2007– 2014 = Progrès réalisés en vue d’éliminer la rougeole au Népal, 2007-2014 Progress towards measles elimination in Nepal, 2007– 2014 = Progrès réalisés en vue d’éliminer la rougeole au Népal, 2007-2014 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Progress towards measles elimination in Nepal, 2007– 2014 = Progrès réalisés (...) en vue d’éliminer la rougeole au Népal, 2007-2014 View/ Open View Statistics Altmetrics Share Citation World Health Organization = Organisation mondiale de la Santé . (‎2016)‎. Progress towards measles elimination in Nepal, 2007– 2014 = Progrès réalisés en vue d’éliminer la rougeole au Népal, 2007-2014. Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire, 91 (‎9)‎, 105 - 120. World Health Organization = Organisation mondiale de la Santé. Journal Weekly Epidemiological Record

2016 WHO

42. Sixth Hands-on Training on Molecular Laboratory Diagnosis of Measles and Rubella, Hong Kong SAR (China), 29 February to 4 March 2016 : report

Sixth Hands-on Training on Molecular Laboratory Diagnosis of Measles and Rubella, Hong Kong SAR (China), 29 February to 4 March 2016 : report Sixth Hands-on Training on Molecular Laboratory Diagnosis of Measles and Rubella, Hong Kong SAR (‎China)‎, 29 February to 4 March 2016 : report JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Sixth Hands-on Training on Molecular (...) Laboratory Diagnosis of Measles and Rubella, Hong Kong SAR (‎China)‎, 29 February to 4 March 2016 : report View/ Open View Statistics Altmetrics Share Citation World Health Organization. Regional Office for the Western Pacific . (‎2016)‎. Sixth Hands-on Training on Molecular Laboratory Diagnosis of Measles and Rubella, Hong Kong SAR (‎China)‎, 29 February to 4 March 2016 : report. Manila : WHO Regional Office for the Western Pacific. Relation Report series ; RS/2016/GE/08(‎CHN)‎ Description 26 p

2016 WHO

43. Measures of measles maternal antibody in infants and cord blood in measles eliminated settings: a systematic review

Measures of measles maternal antibody in infants and cord blood in measles eliminated settings: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2016 PROSPERO

44. The effectiveness of supplementary immunization activities (SIAs) of measles: a systematic review

The effectiveness of supplementary immunization activities (SIAs) of measles: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2016 PROSPERO

46. Application of the World Health Organization Programmatic Assessment Tool for Risk of Measles Virus Transmission-Lessons Learned from a Measles Outbreak in Senegal

Application of the World Health Organization Programmatic Assessment Tool for Risk of Measles Virus Transmission-Lessons Learned from a Measles Outbreak in Senegal WHO | Measles Programmatic Risk Assessment Tool WHO Regional websites Access Immunization, Vaccines and Biologicals Menu Measles Programmatic Risk Assessment Tool The World Health Organization (WHO) measles programmatic risk assessment tool was developed to help national programmes to identify areas not meeting measles programmatic (...) targets, and based on the findings, guide and strengthen measles elimination program activities and reduce the risk of outbreaks. This Excel-based tool assesses subnational programmatic risk as the sum of indicator scores in four categories: population immunity, surveillance quality, program performance, and threat assessment. Each subnational area is assigned to a programmatic risk category of low, medium, high, or very high risk based on the overall risk score. Scoring for each indicator

2015 WHO

47. Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada

Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada | CADTH.ca Find the information you need Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada Published on: June 1, 2015 Project Number: CP0010 Product Line: Result type: Report (...) Background and Context Measles is a highly communicable infectious disease that is spread through droplets from the nose or throat. Vaccination programs have eliminated indigenous measles in Canada; however, outbreaks continue to occur through importations. Recent outbreaks in Canada and the US have highlighted the importance of immunization for the containment of outbreaks. Contact tracing has been implemented to mitigate the spread of measles by identifying susceptible contacts for treatment

2015 CADTH - Health Technology Assessment

48. Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada

Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada Canadian Agency for Drugs and Technologies in Health Agence canadienne des médicaments et des technologies de la santé Supporting Informed Decisions HTA Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada May 2015 Cite as: Budden A, Lee KM, Lam P. Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada [Internet]. Ottawa: CADTH (...) – May 2015 Costs of Contact Tracing Activities Aimed at Reducing the Transmission of Measles in Canada i TABLE OF CONTENTS ABBREVIATIONS ii EXECUTIVE SUMMARY iii 1. BACKGROUND 1 2. CONTEXT AND POLICY ISSUES 2 3. RESEARCH OBJECTIVE 2 4. METHODS 2 4.1 Literature Search 2 4.2 Overview of the Evidence 3 4.1.1 Appraisal 4 4.1.2 Summary 5 5. ECONOMIC EVALUATION 6 5.1 Methods 6 5.1.1 Type of Economic Evaluation 6 5.1.2 Target Population 6 5.1.3 Perspective 6 5.1.4 Scenarios and Data Sources 6 5.1.5 Model

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

49. Public Health Interventions to Reduce the Secondary Spread of Measles

Public Health Interventions to Reduce the Secondary Spread of Measles Canadian Agency for Drugs and Technologies in Health Agence canadienne des médicaments et des technologies de la santé Supporting Informed Decisions Rapid Response Report: Systematic Review Public Health Interventions to Reduce the Secondary Spread of Measles CADTH May 2015Cite as: Foerster V, Perras C, Spry C, Weeks L. Public health interventions to reduce the secondary spread of measles [Internet]. Ottawa: CADTH; 2015 May (...) . (CADTH rapid response report: systematic review). [cited YYYY-MM-DD]. Available from: https://www.cadth.ca/public-health-interventions-reduce-secondary- spread-measles Disclaimer: This report is a review of existing public literature, studies, materials, and other information and documentation (collectively the “source documentation”) that are available to CADTH. The accuracy of the contents of the source documentation on which this report is based is not warranted, assured, or represented in any way

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

50. A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles. (Full text)

A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles. Aerosolized vaccine can be used as a needle-free method of immunization against measles, a disease that remains a major cause of illness and death. Data on the immunogenicity of aerosolized vaccine against measles in children are inconsistent.We conducted an open-label noninferiority trial involving children 9.0 to 11.9 months of age in India who were eligible to receive a first dose of measles vaccine. Children were (...) randomly assigned to receive a single dose of vaccine by means of either aerosol inhalation or a subcutaneous injection. The primary end points were seropositivity for antibodies against measles and adverse events 91 days after vaccination. The noninferiority margin was 5 percentage points.A total of 1001 children were assigned to receive aerosolized vaccine, and 1003 children were assigned to receive subcutaneous vaccine; 1956 of all the children (97.6%) were followed to day 91, but outcome data were

2015 NEJM PubMed abstract

51. Zinc supplementation for the treatment of measles in children. (Full text)

Zinc supplementation for the treatment of measles in children. Measles is still an important cause of childhood morbidity and mortality globally, despite increasing vaccine coverage. Zinc plays a significant role in the maintenance of normal immunological functions, therefore supplements given to zinc-deficient children will increase the availability of zinc and could reduce measles-related morbidity and mortality.To assess the effects of zinc supplementation in reducing morbidity and mortality (...) in India and included 85 children diagnosed with measles and pneumonia. The trial showed that there was no significant difference in mortality between the two groups (risk ratio (RR) 0.34, 95% confidence interval (CI) 0.01 to 8.14). Also, there was no significant difference in time to absence of fever between the two groups (hazard ratio (HR) 1.08, 95% CI 0.67 to 1.74). No treatment-related side effects were reported in either group. The overall quality of the evidence can be described as very low.We

2015 Cochrane PubMed abstract

52. Safety of measles-containing vaccines in 1-year-old children (Full text)

Safety of measles-containing vaccines in 1-year-old children All measles-containing vaccines are associated with several types of adverse events, including seizure, fever, and immune thrombocytopenia purpura (ITP). Because the measles-mumps-rubella-varicella (MMRV) vaccine compared with the separate measles-mumps-rubella (MMR) and varicella (MMR + V) vaccine increases a toddler's risk for febrile seizures, we investigated whether MMRV is riskier than MMR + V and whether either vaccine elevates

2015 EvidenceUpdates PubMed abstract

53. Zinc supplementation for the treatment of measles in children [Cochrane Protocol]

Zinc supplementation for the treatment of measles in children [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2015 PROSPERO

54. Are measles, mumps and rubella vaccines reducing atopic diseases in children?

Are measles, mumps and rubella vaccines reducing atopic diseases in children? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2015 PROSPERO

55. Measly protection: passive immunization for measles, past and present

Measly protection: passive immunization for measles, past and present http://www.evidentlycochrane.net/wp-content/uploads/2014/04/ Search and hit Go By April 11, 2014 // Mother (to District Visitor). “Lumme Miss, there ain’t no danger of infection. Them children wot’s got the measles is at the ‘ead of the bed, and them wot aint is at the foot.” Wood engraving by S. Wood, 1915. : Wellcome Library, London. When I was about seven, I spent a year going through every infectious disease that children (...) could get in those days: whooping cough, rubella, mumps, chickenpox and measles. With measles, you got sore eyes, a hacking cough, a high fever and a rash that covered you all over. At the time, bed rest in a darkened room was compulsory. My mother left the house to do some quick shopping while I was lying abed, but her timing was poor: a thunderstorm was brewing, and while I lay alone with the curtains closed, the chimney was struck by lightning, the room was shaken by a loud explosion and I

2014 Evidently Cochrane

56. Post-exposure passive immunisation for preventing measles. (Full text)

Post-exposure passive immunisation for preventing measles. Measles outbreaks continue to occur in countries with high vaccination coverage. Passive immunisation is generally considered to prevent measles in someone who is not immune and has been exposed to infection. Estimates of effectiveness have varied and no minimum effective dose has been determined.To assess the effectiveness and safety of intramuscular injection or intravenous infusion of immunoglobulins (passive immunisation (...) ) for preventing measles when administered to exposed susceptible people before the onset of symptoms.We searched CENTRAL (2013, Issue 7), MEDLINE (1946 to July week 5, 2013), CINAHL (1981 to August 2013) and EMBASE (1974 to August 2013).We included randomised controlled trials (RCTs), quasi-RCTs and prospective, controlled (cohort) studies if: participants were susceptible and exposed to measles, polyclonal immunoglobulins derived from human sera or plasma were administered intramuscularly or intravenously

2014 Cochrane PubMed abstract

57. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. (Full text)

Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. In low-income countries, live measles vaccine reduces mortality from causes other than measles infection. Such nonspecific effects of vaccines might also be important for the health of children in high-income settings.To examine whether the live vaccine against measles, mumps, and rubella (MMR) is associated with lower rates of hospital admissions for infections among children

2014 JAMA PubMed abstract

58. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. (Abstract)

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Rates of varicella have decreased substantially in countries implementing routine varicella vaccination. Immunisation is possible with monovalent varicella vaccine or a combined measles-mumps-rubella-varicella vaccine (MMRV). We assessed protection against varicella in naive children

2014 Lancet Controlled trial quality: predicted high

59. Routine vitamin A supplementation for the prevention of blindness due to measles infection in children. (Abstract)

Routine vitamin A supplementation for the prevention of blindness due to measles infection in children. Reduced vitamin A concentration increases the risk of blindness in children infected with the measles virus. Promoting vitamin A supplementation in children with measles contributes to the control of blindness in children, which is a high priority within the World Health Organization (WHO) VISION 2020 The Right to Sight Program.To assess the efficacy of vitamin A in preventing blindness (...) in children with measles without prior clinical features of vitamin A deficiency.We searched CENTRAL 2013, Issue 2, MEDLINE (1950 to November week 2, 2013), EMBASE (1974 to November 2013) and LILACS (1985 to November 2013).Randomised controlled trials (RCTs) assessing the efficacy of vitamin A in preventing blindness in well-nourished children diagnosed with measles but with no prior clinical features of vitamin A deficiency.For the original review, two review authors independently assessed studies

2014 Cochrane

60. Public health interventions to reduce secondary spread of measles

Public health interventions to reduce secondary spread of measles Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2014 PROSPERO